nafamostat has been researched along with Carcinoma in 2 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gemcitabine is an effective chemotherapeutic agent for advanced gallbladder cancer." | 1.39 | Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation. ( Fujiwara, Y; Furukawa, K; Haruki, K; Iwase, R; Misawa, T; Ohashi, T; Shiba, H; Uwagawa, T; Yanaga, K, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwase, R | 1 |
| Haruki, K | 1 |
| Fujiwara, Y | 1 |
| Furukawa, K | 1 |
| Shiba, H | 1 |
| Uwagawa, T | 1 |
| Misawa, T | 1 |
| Ohashi, T | 1 |
| Yanaga, K | 1 |
| Yoshii, M | 1 |
| Jikuhara, A | 1 |
| Mori, S | 1 |
| Iwagaki, H | 1 |
| Takahashi, HK | 1 |
| Nishibori, M | 1 |
| Tanaka, N | 1 |
2 other studies available for nafamostat and Carcinoma
| Article | Year |
|---|---|
Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Benzamidines; Carcinoma; Cell Line, Tumor; Cell | 2013 |
Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners.
Topics: Benzamidines; Calcium; Carcinoma; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclooxyg | 2005 |